Valuation: Abbott Laboratories

Market Cap 183B 159B 148B 136B 257B 17,435B 261B 1,747B 685B 8,692B 687B 672B 28,747B P/E 2026 *
30.7x
P/E 2027 * 23.7x
Enterprise Value 207B 180B 168B 154B 291B 19,739B 296B 1,978B 775B 9,841B 778B 761B 32,546B EV / Sales 2026 *
4.12x
EV / Sales 2027 * 3.74x
Free-Float
86.16%
Yield 2026 *
2.41%
Yield 2027 * 2.56%
1 week+1.43%
1 month+15.76%
3 months+18.97%
6 months-0.01%
Current year-12.82%
1 week 89.66
Extreme 89.66
96.5
1 month 77.08
Extreme 77.08
96.5
3 years 69.64
Extreme 69.64
134.1
5 years 69.64
Extreme 69.64
134.1
10 years 34
Extreme 34.003
134.1
Manager TitleAgeSince
Chief Executive Officer 52 30/03/2020
Director of Finance/CFO 53 31/08/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 08/12/2011
Director/Board Member 67 08/12/2011
Director/Board Member 71 15/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+1.43%-18.04%-8.97% 183B
+1.51%+4.17%-2.98%+1.43% 109B
-0.95%-0.49%+6.94%+61.09% 60.57B
+2.37%+2.85%+44.34%+56.22% 51.8B
+2.77%+8.86%-3.49%-38.38% 45.64B
+3.03%+4.44% - - 33.22B
+4.63%+22.04%+10.13%-29.48% 31.49B
+2.05%+6.01%+45.42%-6.11% 24B
+1.86%+8.67%+2.54%+2.12% 22.26B
-0.54%+6.79%-9.83%+2.17% 21.51B
Average +1.86%+5.05%+8.34%+4.45% 44.42B
Weighted average by Cap. +1.71%+3.95%+0.34%+4.36%

Financials

2026 *2027 *
Net sales 50.3B 43.71B 40.75B 37.47B 70.63B 4,795B 71.89B 480B 188B 2,391B 189B 185B 7,907B 54.65B 47.49B 44.27B 40.7B 76.73B 5,209B 78.1B 522B 205B 2,597B 205B 201B 8,589B
Net income 6.25B 5.44B 5.07B 4.66B 8.78B 596B 8.94B 59.74B 23.42B 297B 23.49B 22.97B 983B 7.92B 6.88B 6.42B 5.9B 11.13B 755B 11.32B 75.67B 29.67B 377B 29.75B 29.1B 1,245B
Net Debt 24.17B 21B 19.58B 18B 33.93B 2,304B 34.54B 231B 90.49B 1,148B 90.75B 88.76B 3,798B 21.42B 18.61B 17.35B 15.95B 30.07B 2,042B 30.61B 205B 80.2B 1,018B 80.42B 78.66B 3,366B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
-
Date Price Change
03/08/26 €93.16 +1.33%
31/07/26 €91.94 +0.59%
30/07/26 €91.40 -3.14%
29/07/26 €94.36 +0.21%
28/07/26 €94.16 +2.24%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
107.12USD
Average target price
118.42USD
Spread / Average Target
+10.55%

Quarterly revenue - Rate of surprise